PubRank
Search
About
Ronald G Robinson
Author PubWeight™ 20.02
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.
Biochem J
2005
3.58
2
Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors.
Bioorg Med Chem Lett
2005
3.50
3
Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members.
Mol Cancer Ther
2005
2.23
4
Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft model.
Bioorg Med Chem Lett
2008
1.44
5
Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors.
Bioorg Med Chem Lett
2005
1.27
6
Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity.
Bioorg Med Chem Lett
2007
0.98
7
Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents.
J Med Chem
2003
0.86
8
Optimization of 2,3,5-trisubstituted pyridine derivatives as potent allosteric Akt1 and Akt2 inhibitors.
Bioorg Med Chem Lett
2007
0.86
9
Allosteric inhibitors of Akt1 and Akt2: discovery of [1,2,4]triazolo[3,4-f][1,6]naphthyridines with potent and balanced activity.
Bioorg Med Chem Lett
2008
0.86
10
Discovery of potent and cell-active allosteric dual Akt 1 and 2 inhibitors.
Bioorg Med Chem Lett
2008
0.81
11
Rapid assembly of diverse and potent allosteric Akt inhibitors.
Bioorg Med Chem Lett
2007
0.80
12
The design and synthesis of potent and cell-active allosteric dual Akt 1 and 2 inhibitors devoid of hERG activity.
Bioorg Med Chem Lett
2008
0.79
13
Development of pyridopyrimidines as potent Akt1/2 inhibitors.
Bioorg Med Chem Lett
2008
0.79
14
Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-I.
Bioorg Med Chem Lett
2002
0.78
15
The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases.
Bioorg Med Chem Lett
2002
0.75
16
Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I.
Bioorg Med Chem Lett
2004
0.75